Sulphonamide inhibition studies of the β-carbonic anhydrase GsaCAβ present in the salmon platyhelminth parasite Gyrodactylus salaris

Abstract A β-class carbonic anhydrase (CA, EC 4.2.1.1) present in the genome of the Monogenean platyhelminth Gyrodactylus salaris, a fish parasite, GsaCAβ, has been investigated for its inhibitory effects with a panel of sulphonamides and sulfamates, some of which in clinical use. Several effective GsaCAβ inhibitors were identified, belonging to simple heterocyclic sulphonamides, the deacetylated precursors of acetazolamide and methazolamide (KIsof 81.9–139.7 nM). Many other simple benezene sulphonamides and clinically used agents, such as acetazolamide, methazolamide, ethoxzolamide, dorzolamide, benzolamide, sulthiame and hydrochlorothiazide showed inhibition constants <1 µM. The least effective GsaCAβ inhibitors were 4,6-disubstituted-1,3-benzene disulfonamides, with KIs in the range of 16.9–24.8 µM. Although no potent GsaCAβ-selective inhibitors were detected so far, this preliminary investigation may be helpful for better understanding the inhibition profile of this parasite enzyme and for the potential development of more effective and eventually parasite-selective inhibitors.

[1]  C. Supuran Carbonic Anhydrase Inhibitors from Marine Natural Products , 2022, Marine drugs.

[2]  C. Supuran,et al.  May Sulfonamide Inhibitors of Carbonic Anhydrases from Mammaliicoccus sciuri Prevent Antimicrobial Resistance Due to Gene Transfer to Other Harmful Staphylococci? , 2022, International journal of molecular sciences.

[3]  C. Supuran,et al.  Activation studies with amino acids and amines of a β-carbonic anhydrase from Mammaliicoccus (Staphylococcus) sciuri previously annotated as Staphylococcus aureus (SauBCA) carbonic anhydrase , 2022, Journal of enzyme inhibition and medicinal chemistry.

[4]  C. Supuran Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities , 2022, Journal of enzyme inhibition and medicinal chemistry.

[5]  C. Supuran,et al.  Inhibition studies of the protozoan α-carbonic anhydrase from Trypanosoma cruzi with phenols , 2022, Journal of enzyme inhibition and medicinal chemistry.

[6]  A. Da'dara,et al.  Schistosoma mansoni and the purinergic halo. , 2022, Trends in parasitology.

[7]  C. Supuran,et al.  Seleno Containing Compounds as Potent and Selective Antifungal Agents , 2022, ACS infectious diseases.

[8]  C. Supuran,et al.  Sulfonamide Diuretic Azosemide as an Efficient Carbonic Anhydrase Inhibitor , 2022, Journal of Molecular Structure.

[9]  S. C. Chafe,et al.  Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside , 2022, Cancers.

[10]  C. Supuran,et al.  Structure-activity relationship studies for inhibitors for vancomycin-resistant Enterococcus and human carbonic anhydrases , 2022, Journal of enzyme inhibition and medicinal chemistry.

[11]  N. Delanty,et al.  Acetazolamide: Old drug, new evidence? , 2022, Epilepsia open.

[12]  C. Supuran,et al.  Cloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris , 2022, Journal of enzyme inhibition and medicinal chemistry.

[13]  J. Keiser,et al.  Development of Praziquantel sulphonamide derivatives as antischistosomal drugs , 2022, Journal of enzyme inhibition and medicinal chemistry.

[14]  A. Da'dara,et al.  NAD-catabolizing ectoenzymes of Schistosoma mansoni. , 2022, Biochemical Journal.

[15]  S. Carradori,et al.  Inhibition of Schistosoma mansoni carbonic anhydrase by the antiparasitic drug clorsulon: X-ray crystallographic and in vitro studies , 2022, Acta crystallographica. Section D, Structural biology.

[16]  W. Sly,et al.  Carbonic Anhydrases in Metazoan Model Organisms: Molecules, Mechanisms, and Physiology. , 2022, Physiological reviews.

[17]  C. Supuran,et al.  Coumarins effectively inhibit bacterial α-carbonic anhydrases , 2022, Journal of enzyme inhibition and medicinal chemistry.

[18]  A. Scaloni,et al.  Heterologous expression and biochemical characterisation of the recombinant β-carbonic anhydrase (MpaCA) from the warm-blooded vertebrate pathogen malassezia pachydermatis , 2021, Journal of enzyme inhibition and medicinal chemistry.

[19]  C. Supuran,et al.  Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae , 2021, Journal of enzyme inhibition and medicinal chemistry.

[20]  C. Supuran Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors , 2021, Expert opinion on investigational drugs.

[21]  A. Da'dara,et al.  Schistosome immunomodulators , 2021, PLoS pathogens.

[22]  C. Cerri,et al.  Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives , 2021, Molecules.

[23]  C. Supuran,et al.  Biochemical and structural characterization of beta-carbonic anhydrase from the parasite Trichomonas vaginalis , 2021, Journal of molecular medicine.

[24]  Claudiu T Supuran,et al.  Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets. , 2021, Future medicinal chemistry.

[25]  S. C. Chafe,et al.  Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors , 2021, Science advances.

[26]  C. Supuran,et al.  Structural Insights into Schistosoma mansoni Carbonic Anhydrase (SmCA) Inhibition by Selenoureido-Substituted Benzenesulfonamides. , 2021, Journal of medicinal chemistry.

[27]  C. Supuran Emerging role of carbonic anhydrase inhibitors. , 2021, Clinical science.

[28]  C. Supuran,et al.  Advances in the discovery of novel agents for the treatment of glaucoma , 2021, Expert opinion on drug discovery.

[29]  C. Supuran,et al.  A Highlight on the Inhibition of Fungal Carbonic Anhydrases as Drug Targets for the Antifungal Armamentarium , 2021, International journal of molecular sciences.

[30]  J. Kaur,et al.  Structure-Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae. , 2021, ACS infectious diseases.

[31]  C. B. Mishra,et al.  Discovery of Potent Carbonic Anhydrase Inhibitors as Effective Anticonvulsant Agents: Drug Design, Synthesis, and In Vitro and In Vivo Investigations. , 2021, Journal of medicinal chemistry.

[32]  J. Bron,et al.  Geographical distribution of Gyrodactylus salaris Malmberg, 1957 (Monogenea, Gyrodactylidae) , 2021, Parasites & vectors.

[33]  C. Supuran Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders , 2021, Journal of enzyme inhibition and medicinal chemistry.

[34]  S. Carradori,et al.  Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase , 2021, Journal of enzyme inhibition and medicinal chemistry.

[35]  S. Carradori,et al.  Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment , 2020, Metabolites.

[36]  C. Supuran,et al.  Antibacterial carbonic anhydrase inhibitors: an update on the recent literature , 2020, Expert opinion on therapeutic patents.

[37]  C. B. Mishra,et al.  Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? , 2020, Medicinal research reviews.

[38]  C. Supuran,et al.  Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action , 2020, Journal of medicinal chemistry.

[39]  C. Supuran,et al.  Sulfonamide Inhibition Studies of an α-Carbonic Anhydrase from Schistosoma mansoni, a Platyhelminth Parasite Responsible for Schistosomiasis , 2020, International journal of molecular sciences.

[40]  C. Supuran,et al.  Crystal structure and chemical inhibition of essential schistosome host-interactive virulence factor carbonic anhydrase SmCA , 2019, Communications Biology.

[41]  C. Supuran Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors , 2018, Expert opinion on investigational drugs.

[42]  Alexa J. Lamm,et al.  Acetazolamide promotes decreased consumption of carbonated drinks and weight loss , 2018, Oxford medical case reports.

[43]  C. Supuran Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas , 2018, Expert opinion on therapeutic patents.

[44]  C. Supuran Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases , 2018, Expert opinion on therapeutic patents.

[45]  C. B. Mishra,et al.  Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal. , 2018, European journal of medicinal chemistry.

[46]  M. Kent,et al.  Genomic signatures of parasite-driven natural selection in north European Atlantic salmon (Salmo salar). , 2018, Marine genomics.

[47]  C. Supuran Carbonic Anhydrases and Metabolism , 2018, Metabolites.

[48]  H. Hansen,et al.  Infections with Gyrodactylus spp. (Monogenea) in Romanian fish farms: Gyrodactylus salaris Malmberg, 1957 extends its range , 2016, Parasites & Vectors.

[49]  C. Supuran,et al.  Ascaris lumbricoides β carbonic anhydrase: a potential target enzyme for treatment of ascariasis , 2015, Parasites & Vectors.

[50]  C. Supuran,et al.  Drosophila melanogaster: a model organism for controlling Dipteran vectors and pests , 2015, Journal of enzyme inhibition and medicinal chemistry.

[51]  Harlan R. Barker,et al.  Beta carbonic anhydrases: novel targets for pesticides and anti-parasitic agents in agriculture and livestock husbandry , 2014, Parasites & Vectors.

[52]  P. D. Harris,et al.  Same barcode, different biology: differential patterns of infectivity, specificity and pathogenicity in two almost identical parasite strains. , 2014, International journal for parasitology.

[53]  C. Supuran,et al.  Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. , 2013, Journal of medicinal chemistry.

[54]  C. Supuran,et al.  Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. , 2012, Journal of medicinal chemistry.

[55]  C. Supuran,et al.  Carbonic Anhydrase Inhibitors: Inhibition of Human Erythrocyte Isozymes I and II with a Series of Phenolic Acids , 2010, Chemical biology & drug design.

[56]  B. Schelkle,et al.  Treatment of gyrodactylid infections in fish. , 2009, Diseases of aquatic organisms.

[57]  Claudiu T Supuran,et al.  Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies. , 2008, Bioorganic & medicinal chemistry letters.

[58]  Claudiu T. Supuran,et al.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.

[59]  J. Utzinger,et al.  Drugs for treating urinary schistosomiasis , 2014, The Cochrane database of systematic reviews.

[60]  C. Supuran,et al.  Inhibition of the archaeal beta-class (Cab) and gamma-class (Cam) carbonic anhydrases. , 2007, Current Topics in Medicinal Chemistry.

[61]  C. Supuran,et al.  Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. , 2006, Journal of medicinal chemistry.

[62]  C. Supuran,et al.  Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase. , 2004, Bioorganic & medicinal chemistry letters.

[63]  S. Krungkrai,et al.  Plasmodium falciparum Carbonic Anhydrase is a Possible Target for Malaria Chemotherapy , 2004, Journal of enzyme inhibition and medicinal chemistry.

[64]  Christopher C. E. Hopkins,et al.  Introduced Marine Organisms in Norwegian Waters, Including Svalbard , 2002 .

[65]  L. Chitsulo,et al.  Therapeutic and Operational Profiles of Metrifonate and Praziquantel in Schistosoma haematobium Infection , 1999, Arzneimittelforschung.

[66]  T. Bakke,et al.  Aqueous aluminium eliminates Gyrodactylus salaris (Platyhelminthes, Monogenea) infections in Atlantic salmon , 1999, Parasitology.

[67]  C. Supuran,et al.  Carbonic anhydrase inhibitors - Part 57 : Quantum chemical QSAR of a group of 1,3,4-thiadiazole- and 1,3,4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties , 1999 .

[68]  G. Schmahl The chemotherapy of monogeneans which parasitize fish: a review. , 1991, Folia parasitologica.

[69]  R. Khalifah,et al.  The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. , 1971, The Journal of biological chemistry.